Trxade Group, Inc.(MEDS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDS Trxade Group, Inc.

Trading 11-04 12:57:40 EST

7.59

+0.00

0.00%

High7.59	Low7.59	Vol0.00
Open7.59	D1 Closing7.59	Amplitude0.00%
Mkt Cap11.07M	Tradable Cap5.58M	Total Shares1.46M
T/O141.56K	T/O Rate0.00%	Tradable Shares734.54K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MEDS","market":"US","secType":"STK","nameCN":"Trxade Group, Inc.","latestPrice":7.59,"timestamp":1726862400000,"preClose":7.59,"halted":8,"volume":0,"delay":0,"floatShares":734539,"shares":1458659,"eps":4.059344,"marketStatus":"Trading","change":0,"latestTime":"11-04 12:57:40 EST","open":7.59,"high":7.59,"low":7.59,"amount":141557.8217,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.059344,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1730754000000},"marketStatusCode":2,"symbolChange":{"newSymbol":"SCNX","executeDate":"2024-09-23"},"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":7.59,"volumeRatio":0},"requestUrl":"/m/hq/s/MEDS","defaultTab":"news","newsList":[{"id":"2469673510","title":"TRxADE Health Inc -Scienture Holdings Stock Will Begin Trading Under New Ticker Symbol Nasdaq:Scnx on September 23","url":"https://stock-news.laohu8.com/highlight/detail?id=2469673510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469673510?lang=en_us&edition=fundamental","pubTime":"2024-09-20 23:59","pubTimestamp":1726847975,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240920:nFWN3L21JR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDS","BK4122","BK4167"],"gpt_icon":0},{"id":"2469514673","title":"TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2469514673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469514673?lang=en_us&edition=fundamental","pubTime":"2024-09-20 23:59","pubTimestamp":1726847975,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240920:nFWN3L21JR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDS","BK4122","BK4167"],"gpt_icon":0},{"id":"2469167352","title":"TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2469167352","media":"GlobeNewswire","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469167352?lang=en_us&edition=fundamental","pubTime":"2024-09-20 23:59","pubTimestamp":1726847940,"startTime":"0","endTime":"0","summary":"TAMPA, FL and COMMACK, NY, Sept.  20, 2024  (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced tha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/20/2949802/0/en/TRxADE-Health-Inc-Announces-Name-Change-to-Scienture-Holdings-Inc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","BK4122","QID","BK4167","TQQQ","NQmain","PSQ","QLD","BK4139","MEDS","SQQQ","MNQmain","VIRI"],"gpt_icon":1},{"id":"2457729920","title":"TRxADE Health, Inc. Announces New Addition and Changes to Scienture, Llc’s Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457729920?lang=en_us&edition=fundamental","pubTime":"2024-08-05 20:01","pubTimestamp":1722859260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240805:nTUA7ZBJW3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TISI","VIRI","MEDS","BK4120","BK4122","BK4139","BK4167"],"gpt_icon":0},{"id":"2457729660","title":"TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729660","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457729660?lang=en_us&edition=fundamental","pubTime":"2024-08-05 20:01","pubTimestamp":1722859260,"startTime":"0","endTime":"0","summary":"TAMPA, FL and COMMACK, NY, Aug.  05, 2024  (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/08/05/2924257/0/en/TRxADE-Health-Inc-Announces-New-Addition-and-Changes-to-Scienture-LLC-s-Executive-Leadership-Team.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4122","BK4167","BK4585","GB00BDT5M118.USD","LU1992135399.USD","LU1992135472.HKD","MEDS","BK4588","TISI","BK4198","BK4139","LU2272731600.USD","BK4120","COO","LU2272731782.SGD","VIRI"],"gpt_icon":0},{"id":"2456194464","title":"Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2456194464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2456194464?lang=en_us&edition=fundamental","pubTime":"2024-08-01 05:51","pubTimestamp":1722462718,"startTime":"0","endTime":"0","summary":"Trxade Group (MEDS) has issued an announcement. On July 25, 2024, TRxADE HEALTH, INC. finalized a merger with Scienture, Inc., wherein Scienture be...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/trxade-groups-strategic-merger-and-rebranding-as-scienture-holdings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/trxade-groups-strategic-merger-and-rebranding-as-scienture-holdings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","BK4122","MEDS"],"gpt_icon":0},{"id":"2454249413","title":"TRxADE Health, Scienture Complete Business Combination; TRxADE Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2454249413","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454249413?lang=en_us&edition=fundamental","pubTime":"2024-07-26 23:20","pubTimestamp":1722007243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["MEDS","BK4167","BK4122"],"gpt_icon":0},{"id":"2454223903","title":"TRxADE Health, Scienture Complete Business Combination; TRxADE Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2454223903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454223903?lang=en_us&edition=fundamental","pubTime":"2024-07-26 23:20","pubTimestamp":1722007243,"startTime":"0","endTime":"0","summary":"TRxADE Health  and Scienture said Friday they have completed their all-stock business combination valued at $103 million.Under the deal, TRxADE acquired Scienture's assets in exchange for common stock and non-voting convertible preferred stock and will rebrand as Scienture Holdings and continue to trade on Nasdaq.Scienture stockholders will own about 83% of the combined entity, while TRxADE stockholders will hold about 17%.Suren Ajjarapu will remain chairman and chief executive officer of the combined company.TRxADE shares rose more than 18% in recent trading.Price: 13.54, Change: +1.84, Percent Change: +15.73","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDS","BK4122","BK4167"],"gpt_icon":0},{"id":"2454421321","title":"Trxade Health acquires Scienture in all-stock transaction valued at $103M","url":"https://stock-news.laohu8.com/highlight/detail?id=2454421321","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454421321?lang=en_us&edition=fundamental","pubTime":"2024-07-26 22:47","pubTimestamp":1722005253,"startTime":"0","endTime":"0","summary":"TRxADE HEALTH  and Scienture has announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction. TRxADE acquired all of Scienture’s assets in exchange for shares of TRxADE stock, in a combination of common stock and non-voting convertible preferred stock.  TRxADE will change its name to “Scienture Holdings” after the future conversion of the non-voting convertible preferred stock, and the combined company is intended to continue as a Nasdaq-listed Co. The Business Combination results in a combined Co. that will be focused on bringing to market innovative branded, specialty pharmaceutical products that significantly enhance the standard of care, while adding value to patients, caregivers and the healthcare system.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4129020-trxade-health-acquires-scienture-in-all-stock-transaction-valued-at-103m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4122","MEDS","BK4167"],"gpt_icon":0},{"id":"2454956340","title":"TRxADE Health Shares up 21.3% After Co to Merge With Scienture in $103 Mln Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2454956340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454956340?lang=en_us&edition=fundamental","pubTime":"2024-07-26 21:33","pubTimestamp":1722000793,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240726:nFWN3JI1TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDS","BK4167","BK4122"],"gpt_icon":0},{"id":"2454341726","title":"TRxADE Health Shares Jump 46.3% to $17.01 Premarket After Co to Merge With Scienture in $103 Mln Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2454341726","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454341726?lang=en_us&edition=fundamental","pubTime":"2024-07-26 20:36","pubTimestamp":1721997401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240726:nL4N3JI159:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","BK4122","MEDS"],"gpt_icon":0},{"id":"2454346091","title":"TRxADE Health Merges with Scienture in $103M Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2454346091","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454346091?lang=en_us&edition=fundamental","pubTime":"2024-07-26 20:23","pubTimestamp":1721996580,"startTime":"0","endTime":"0","summary":"TRxADE Health has closed a business combination with the privately-held pharmaceutical company Scienture in a $103 million stock deal.The pharmaceutical exchange platform provider said Friday that it has acquired all of Scienture's assets in exchange for TRxADE stock.The combined company will go forward under the name Scienture Holdings and trade on the Nasdaq. The company's board will include TRxADE's directors and two additional members designated by Scienture.Scienture stockholders are expected to own about 82.99% of the combined company, with current TRxADE owning the rest.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4122","MEDS"],"gpt_icon":0},{"id":"2454345611","title":"BRIEF-TRxADE Health Announces Business Combination With Scienture","url":"https://stock-news.laohu8.com/highlight/detail?id=2454345611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454345611?lang=en_us&edition=fundamental","pubTime":"2024-07-26 20:02","pubTimestamp":1721995325,"startTime":"0","endTime":"0","summary":"July 26  - TRxADE Health Inc   :   * TRXADE HEALTH, INC. ANNOUNCES BUSINESS COMBINATION WITH SCIENTURE, INC., IN A TRANSACTION VALUED AT $103 MILLION   * TRXADE HEALTH INC - TO BE RENAMED SCIENTURE HOLDINGS, INC.   * TRXADE HEALTH INC - CEO SUREN AJJARAPU TO CONTINUE AS CEO OF COMBINED COMPANYSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDS","BK4167","BK4122"],"gpt_icon":0},{"id":"2454345782","title":"TRxADE Health Inc - to Be Renamed Scienture Holdings, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454345782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454345782?lang=en_us&edition=fundamental","pubTime":"2024-07-26 20:01","pubTimestamp":1721995260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240726:nTUA9B5G4Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDS","BK4122","BK4167"],"gpt_icon":0},{"id":"2454345098","title":"TRxADE Health, Inc. Announces Business Combination With Scienture, Inc., in a Transaction Valued at $103 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2454345098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454345098?lang=en_us&edition=fundamental","pubTime":"2024-07-26 20:01","pubTimestamp":1721995260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240726:nTUA9B5G4Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","MEDS","BK4122"],"gpt_icon":0},{"id":"2454345062","title":"TRxADE Health Inc - CEO Suren Ajjarapu to Continue as CEO of Combined Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2454345062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454345062?lang=en_us&edition=fundamental","pubTime":"2024-07-26 20:01","pubTimestamp":1721995260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240726:nTUA9B5G4Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDS","BK4122","BK4167"],"gpt_icon":0},{"id":"2454346633","title":"TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2454346633","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454346633?lang=en_us&edition=fundamental","pubTime":"2024-07-26 20:01","pubTimestamp":1721995260,"startTime":"0","endTime":"0","summary":"Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in anall-stocktransaction valued at $103 million.The Business Combination is structured as a stock for stock exchange whereby all of the outstanding equity securities of Scienture are to be exchanged for a combination of TRxADE common stock and non-voting convertible preferred stock. Upon completion of the proposed Business Combination and future conversion of the non-voting convertible preferred stock, on a pro forma basis and based upon the number of TRxADE shares to be issued in the proposed Business Combination, current Scienture stockholders are expected to own approximately 82.99% of the equity interests in the combined company and current TRxADE stockholders are expected to own approximately 17.0","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0rj0yN2b99LftOugVn1NMA--~B/aD03Mjt3PTE4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/eed534f3b318b7091636ec2df4d9ae2a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0rj0yN2b99LftOugVn1NMA--~B/aD03Mjt3PTE4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/eed534f3b318b7091636ec2df4d9ae2a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trxade-health-inc-announces-business-120100325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4167","MEDS","BK4122"],"gpt_icon":0},{"id":"2450304995","title":"BRIEF-TRxADE Health, Inc. Announces Special Cash Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2450304995","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450304995?lang=en_us&edition=fundamental","pubTime":"2024-07-09 20:15","pubTimestamp":1720527338,"startTime":"0","endTime":"0","summary":"July 9 (Reuters) - TRxADE Health Inc   :   * TRXADE HEALTH, INC. ANNOUNCES SPECIAL CASH DIVIDEND   * TRXADE HEALTH INC - DECLARES SPECIAL CASH DIVIDEND OF $1.50 PER SHARESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDS","BK4122","BK4167"],"gpt_icon":0},{"id":"2450047319","title":"Trxade Group declares $1.50 special dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2450047319","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450047319?lang=en_us&edition=fundamental","pubTime":"2024-07-09 20:06","pubTimestamp":1720526805,"startTime":"0","endTime":"0","summary":"Trxade Group (NASDAQ:MEDS) declares $1.50/share special dividend.\nPayable July 24; for shareholders of record July 19; ex-div July 19.\nSee MEDS Dividend Scorecard, Yield Chart, & Dividend Growth.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4122856-trxade-group-declares-150-special-dividend","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MNQmain","US12M.BOND","SQQQ","US6M.BOND","US912797GL51.BOND","QID","US7Y.BOND","BK4122","BK4167","US912797GB79.BOND","MEDS","QLD",".IXIC","US3Y.BOND","NQmain","US912797HE00.BOND","US10Y.BOND","US2Y.BOND","US30Y.BOND","US5Y.BOND","TQQQ","QQQ","PSQ","US912797GK78.BOND","US912797GW17.BOND"],"gpt_icon":0},{"id":"2450046600","title":"TRxADE Health, Inc. Announces Special Cash Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2450046600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450046600?lang=en_us&edition=fundamental","pubTime":"2024-07-09 20:05","pubTimestamp":1720526700,"startTime":"0","endTime":"0","summary":"TRxADE Health, Inc. Announces Special Cash Dividend","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240709:nTUA7LNHHQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","MEDS","BK4122"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rx.trxade.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.0641},{"period":"6month","weight":0.2067},{"period":"1year","weight":0.2864},{"period":"ytd","weight":0.4607}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.062063},{"month":2,"riseRate":0.5,"avgChangeRate":0.3179},{"month":3,"riseRate":0.6,"avgChangeRate":0.056183},{"month":4,"riseRate":0.4,"avgChangeRate":-0.096971},{"month":5,"riseRate":0.2,"avgChangeRate":-0.125905},{"month":6,"riseRate":1,"avgChangeRate":0.638787},{"month":7,"riseRate":0.6,"avgChangeRate":-0.057804},{"month":8,"riseRate":0.4,"avgChangeRate":-0.102104},{"month":9,"riseRate":0.2,"avgChangeRate":-0.031547},{"month":10,"riseRate":0,"avgChangeRate":-0.211606},{"month":11,"riseRate":0.5,"avgChangeRate":-0.043798},{"month":12,"riseRate":0,"avgChangeRate":-0.19739}],"exchange":"NASDAQ","name":"Trxade Group, Inc.","nameEN":"Trxade Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Trxade Group, Inc.(MEDS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Trxade Group, Inc.(MEDS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Trxade Group, Inc.,MEDS,Trxade Group, Inc.股票,Trxade Group, Inc.股票老虎,Trxade Group, Inc.股票老虎国际,Trxade Group, Inc.行情,Trxade Group, Inc.股票行情,Trxade Group, Inc.股价,Trxade Group, Inc.股市,Trxade Group, Inc.股票价格,Trxade Group, Inc.股票交易,Trxade Group, Inc.股票购买,Trxade Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Trxade Group, Inc.(MEDS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Trxade Group, Inc.(MEDS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}